120 related articles for article (PubMed ID: 2442320)
1. Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Fenaux P; Jouet JP; Bauters F; Lai JL; Lepelley P
J Clin Oncol; 1987 Aug; 5(8):1304-5. PubMed ID: 2442320
[No Abstract] [Full Text] [Related]
2. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
3. Ten years' experience in patients with osteogenic sarcoma in Finland.
Elomaa I; Siimes MA; Blomqvist C; Karaharju E; Ryöppy S; Laasonen E; Holmström T
Eur J Surg Oncol; 1990 Apr; 16(2):147-52. PubMed ID: 1691110
[TBL] [Abstract][Full Text] [Related]
4. Acute lymphoblastic leukemia with t(1;11)(p32;q23) in a patient treated for osteogenic sarcoma.
Pinto LI; Marczyk FF; Brunetto AL
Pediatr Hematol Oncol; 1998; 15(1):93-5. PubMed ID: 9509513
[No Abstract] [Full Text] [Related]
5. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
Albain KS; Le Beau MM; Ullirsch R; Schumacher H
Genes Chromosomes Cancer; 1990 May; 2(1):53-8. PubMed ID: 2177642
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
[No Abstract] [Full Text] [Related]
7. [The reproduction in France of Rosen's protocol for osteosarcomas].
Brunat-Mentigny M; Demaille MC; Quitana E; Olive D; Bachelot C; Boitetot A; Gentet JC; Noir P; Roche H; Thyss JP
Bull Cancer; 1988; 75(2):201-6. PubMed ID: 2451955
[TBL] [Abstract][Full Text] [Related]
8. The multi-institutional osteosarcoma study: an update.
Link MP
Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
[No Abstract] [Full Text] [Related]
9. Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
Pratt CB; Epelman S; Jaffe N
Cancer Treat Rep; 1987 Apr; 71(4):421-3. PubMed ID: 2435408
[No Abstract] [Full Text] [Related]
10. [Mirror-image osteosarcoma of the radius. A case].
Baranzelli MC; Bouretz JC; Dusol F; Gosselin P; Demaille MC
Presse Med; 1989 Jun; 18(25):1245-8. PubMed ID: 2472633
[TBL] [Abstract][Full Text] [Related]
11. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Ekert H; Tiedemann K
Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
[No Abstract] [Full Text] [Related]
13. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Chuman H; Fukuma H; Beppu Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetics reveals complex karyotype in apparent t(8;13) therapy-related acute myeloid leukemia M2 after fibrosarcoma.
Soares-Ventura EM; Mkrtchyan H; de Jesus Marques-Salles T; Silva M; Santos N; de Araujo Silva Amaral B; Liehr T; Abdelhay E; Silva ML; Muniz MT
Leuk Res; 2011 May; 35(5):e27-9. PubMed ID: 21329977
[No Abstract] [Full Text] [Related]
15. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Miser JS; Krailo M
Cancer Treat Res; 1993; 62():287-91. PubMed ID: 7682089
[No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
[TBL] [Abstract][Full Text] [Related]
17. Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent.
Scallan PJ; Kettler AH; Levy ML; Tschen JA
Cancer; 1988 Dec; 62(12):2532-6. PubMed ID: 2461249
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced hypomagnesemia and cardiac dysrhythmia.
Bashir H; Crom D; Metzger M; Mulcahey J; Jones D; Hudson MM
Pediatr Blood Cancer; 2007 Nov; 49(6):867-9. PubMed ID: 16619211
[TBL] [Abstract][Full Text] [Related]
19. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
[TBL] [Abstract][Full Text] [Related]
20. [Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Kalifa C; Mlika N; Dubousset J; Contesso G; Vanel D; Lumbroso J
Bull Cancer; 1988; 75(2):207-11. PubMed ID: 2451956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
